Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
imunogeninis poveikis
immunogenicity
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
imunogeninis poveikis.)
(see immunogenicity.)
Last Update: 2012-04-11
Usage Frequency: 4
Quality:
zostavax imunogeninis poveikis
immunogenicity of zostavax
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
gali pasireikšti imunogeninis poveikis.
there is potential for immunogenicity.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ištiriamas galimas imunogeninis ir imunotoksinis poveikis.
potential immunogenic and immunotoxic effects shall be studied.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
imunogeninis iblias poveikis buvo vertinamas anksčiau gydytiems pacientams.
the immunogenicity of iblias was evaluated in previously treated patients.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
imunogeniškumas ir imunotoksiškumas. ištiriamas galimas imunogeninis ir imunotoksinis poveikis.
immunogenicity and immunotoxicity: potential immunogenic and immunotoxic effects shall be studied.
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
kaip ir prieš visus terapinius baltymus, gali pasireikšti imunogeninis poveikis.
as with all therapeutic proteins, there is potential for immunogenicity.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kai ir vartojant bet kokių gydymui skirtų baltymų, gali pasireikšti imunogeninis poveikis.
as with all therapeutic proteins, there is a potential for immunogenicity.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vartojant gydomuosius baltymus, pavyzdžiui, ofatumumabą, yra tikimybė, kad pasireikš imunogeninis poveikis.
there is a potential for immunogenicity with therapeutic proteins such as ofatumumab.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
kaip ir vartojant bet kokių gydomąjį poveikį sukeliančių baltymų, gydymo zaltrap metu gali pasireikšti imunogeninis poveikis.
as with all therapeutic proteins, there is a potential for immunogenicity with zaltrap.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
visuose šiuose tyrimuose buvo tiriamas vakcinos gebėjimas paskatinti h5n1 viruso antikūnų gamybą (imunogeninis poveikis).
all of the studies looked at the ability of the vaccine to trigger the production of antibodies (‘immunogenicity’) against h5n1.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Įrodyta, kad praėjus šešioms savaitėms po vienkartinės vakcinos dozės sušvirkštimo, dabartinės šaldytuve stabilios formos imunogeninis poveikis panašus į ankstesnės proquad formos.
immunogenicity immunogenicity was studied in children 12 through 23 months of age with a negative clinical history of measles, mumps, rubella, and varicella who participated in 5 randomized clinical trials. the immunogenicity of the current refrigerator-stable formulation was shown to be similar to the immunogenicity of the earlier formulation of proquad six weeks after a single dose of the vaccine.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
zostavax imunogeninis poveikis imuninis atsakas po vakcinacijos tirtas pslelins profilaktikos tyrimo (shingles prevention study sps) 1 395 tiriamj pogrupyje.
immunogenicity of zostavax within the shingles prevention study (sps) , immune responses to vaccination were evaluated in a subset of the enrolled subjects (n=1395) .
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
zostavax imunogeninis poveikis imuninis atsakas po vakcinacijos tirtas pūslelinės profilaktikos tyrimo (shingles prevention study – sps) 1 395 tiriamųjų pogrupyje.
immunogenicity of zostavax within the shingles prevention study (sps), immune responses to vaccination were evaluated in a subset of the enrolled subjects (n=1395).
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
imunogeninis vienkartinės ankstesnės formos proquad dozės poveikis buvo lygintas su imunogeniniu atskirų vakcinos dalių (vėjaraupių gyvosios vakcinos (oka/merck) ir vakcinos nuo tymų, kiaulytės, raudonukės, pagamintos merck & co., inc.) vienkartinių dozių, kurios šiuo metu keliose šalyse vartojamos įprastiniam skiepijimui, poveikiu.
the immunogenicity of a single dose of an earlier formulation of proquad was comparable to the immunogenicity of a single dose of its individual component vaccines (varicella vaccine live (oka/merck) and the measles, mumps, and rubella vaccine manufactured by merck & co., inc.), currently used in routine vaccination in some countries.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
Warning: Contains invisible HTML formatting